Pseudomonas aeruginosa
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | - |
Imipenem | 93 |
|
| Azithromycin | - |
Levofloxacin | 76 |
|
| Aztreonam | 82 |
Meropenem | 96 |
|
| Cefazolin | - |
Moxifloxacin | +
|
|
| Cefepime | 90 |
Nitrofurantoin | 1
|
|
| Ceftazidime | 90 |
Oxacillin/Naf | - |
|
| Ceftriaxone | 10 |
Penicillin | - |
|
| Cefuroxime | - |
Piperacillin | 96
|
|
| Ciprofloxacin | 78 |
Piperacillin/tazo | 98 |
|
| Clarithromycin | - |
Ticarcillin/Clav | 90 |
|
| Clindamycin | - |
Tobramycin | 95 |
|
| Doxycycline | - |
TMP/SMX | - |
|
| Erythromycin | - |
Unasyn/Aug | - |
|
| Gentamicin | 86 |
Vancomycin | - |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections